T. Lung

发表

Is time to first recurrence of atrial fibrillation correlated with atrial fibrillation burden

K. Ellenbogen, M. Wood, Francisco J. Pérez, 2005 .

Cycle-time and residence-time density approximations in a stochastic model for circulatory transport.

P. Lánský, C. E. Smith, T. Lung, 1997, Bulletin of mathematical biology.

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients

M. Price, G. Stone, A. Kirtane, 2020, Circulation. Cardiovascular interventions.

ONE MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS: PRIMARY RESULTS FROM THE ONYX ONE CLEAR STUDY

M. Price, G. Stone, A. Kirtane, 2020 .

Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study

M. Price, G. Stone, S. Windecker, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endocarditis After Transcatheter Pulmonary Valve Replacement.

D. McElhinney, P. Ewert, R. Padera, 2018, Journal of the American College of Cardiology.

Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results

M. Price, G. Stone, A. Kirtane, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Coronary Stenting in Patients With Small Coronary Arteries at High Risk of Bleeding: Onyx ONE Clear

M. Price, G. Stone, T. Nazif, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials

J. Cheatham, D. McElhinney, L. Benson, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve.

J. Cheatham, L. Benson, A. Crean, 2017, JACC. Cardiovascular interventions.

Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study

J. Cheatham, D. McElhinney, D. Turner, 2017, The Journal of thoracic and cardiovascular surgery.

The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation: the Vitatron Selection AFm Registry study

M. Reiter, F. T. T. Investigators, R. Canby, 2010, Journal of Interventional Cardiac Electrophysiology.

Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers.

M. Reiter, D. Munneke, A. Shalaby, 2009, Journal of electrocardiology.

Is time to first recurrence of atrial fibrillation correlated with atrial fibrillation burden?

Kenneth A Ellenbogen, K. Ellenbogen, M. Wood, 2006, The American journal of cardiology.

Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).

C. O'connor, D. Whellan, T. Lung, 2008, American heart journal.

Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.

M. Price, G. Stone, Z. Ali, 2022, JACC. Cardiovascular interventions.

Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits

D. Turner, D. Levi, T. Jones, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Changes in Intrathoracic Fluid Index predict subsequent adverse events: Results of the Multi-site Program to Access and Review Trending INformation and Evaluate CoRrelation to Symptoms in Patients with Heart Failure (PARTNERS HF) Trial

C. O'connor, C. Porter, D. Whellan, 2008 .

Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.

M. Price, G. Stone, S. Windecker, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation, improved right ventricular outflow tract obstruction and improved quality of life.

P. Ewert, A. Hager, L. Benson, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results from RESOLUTE ONYX Postapproval Study

M. Price, R. Mehran, A. Kirtane, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Aortic annulus diameter and valve design each determine the valve size implanted.

R. Busund, U. V. von Oppell, N. Masani, 2012, The Journal of heart valve disease.

Endocarditis After Transcatheter Pulmonary Valve Replacement.

D. McElhinney, P. Ewert, R. Padera, 2018, Journal of the American College of Cardiology.

FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT

M. Price, G. Stone, A. Kirtane, 2021 .